| Seth Lederman |
Seth Lederman is the founder of Ivrea Pharmaceuticals, Inc. (founded in 2005), Tonix Pharmaceuticals, Inc. (founded in 2007), Tonix Pharmaceuticals Holding Corp. (founded in 2007), and Targent Pharmaceuticals LLC (founded in 2000). Dr. Lederman was also the founder of Validus LLC, Vela Pharmaceuticals, Inc... Dr. Lederman's current job(s) included Chairman & Chief Executive Officer at Starling Pharmaceuticals, Inc. (since 2011), Chairman at Krele LLC (since 2010), President & Director at Tonix Pharmaceuticals (Canada), Inc. (since 2013), Managing Member at Lederman & Co. LLC (since 2002), Manager at L&L Technologies, Inc. (since 1996), Managing Member at Plumbline LLC (since 2002), and Managing Member at Lederman Seth Co. LLC (since 2007). Dr. Lederman's former job(s) include Chairman, President & Chief Executive Officer at Tamandare Explorations, Inc. (2011), Chairman & Chief Executive Officer at Leder Laboratories, Inc. (2011-2018), Chairman at Validus Pharmaceuticals LLC (2007-2008), Chairman at Fontus Pharmaceuticals, Inc. (2007-2008), Director at The Research Corp. of Long Island, Inc. (2006-2011), Laboratory Director at Columbia University College of Physicians & Surgeons, Director at Tonix Pharmaceuticals (Barbados) Ltd. (2013-2015), Director at Tonix Pharma Ltd. (2014-2015), Director at Tonix Pharma Holdings Ltd. (2014-2015), Director at Konanda Pharma Fund I LP (2007-2008), Associate Professor at The Trustees of Columbia University in The City of New York (1996-2017), Member at The U.S.-Japan Business Council, Inc., Managing Partner at Konanda Pharma Partners LLC (2007-2008), and Managing Partner at Konanda General Partner LLC (2007-2008). Dr. Lederman's education history includes an undergraduate degree from Princeton University (conferred in 1979) and a doctorate degree from Columbia University College of Physicians & Surgeons (conferred in 1983). |
| Bruce L. Daugherty |
Bruce L. Daugherty is currently the Executive Vice President-Research at Tonix Pharmaceuticals Holding Corp. He previously worked as the Director at Tonix Pharmaceuticals (Canada), Inc. from 2013 to 2016 and as the Director at Tonix Pharma Ltd. from 2015 to 2016. Dr. Daugherty obtained his undergraduate degree from Washington University in St. Louis, his graduate degree from Rutgers State University of New Jersey, his doctorate from Robert Wood Johnson Medical School, and his MBA from Goizueta Business School-Emory. |
| Gregory M. Sullivan |
Gregory M. Sullivan is currently the Secretary & Chief Medical Officer at Tonix Pharmaceuticals Holding Corp. He previously worked as an Assistant Professor at Columbia University Medical Center and as a Member-Institutional Review Board at The New York State Psychiatric Institute. Dr. Sullivan obtained his undergraduate degree from the University of California, Berkeley and his doctorate from Columbia University College of Physicians & Surgeons. |
| Bradley Saenger |
Bradley Saenger is currently a Director at Tonix Pharma Holdings Ltd. and the Chief Financial Officer & Treasurer at Tonix Pharmaceuticals Holding Corp. He previously worked as an Associate Director-Accounting at Vertex Pharmaceuticals, Inc. from 2011 to 2012 and as a Manager-Corporate Accounting & Consolidations at Alere, Inc. from 2007 to 2011. Mr. Saenger completed his undergraduate degree at the University of South Africa. |
| Zeil Rosenberg |
Zeil Rosenberg is currently the Executive Vice President-Medical at Tonix Pharmaceuticals Holding Corp. Prior to this, he worked as the Chief Technical Officer-Immunization at the US Agency for International Development and as the Vice President-Medical Affairs at Admera Health LLC. Dr. Rosenberg has a graduate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from Stanford University, and a doctorate degree from The University of California, San Francisco. |
| Jessica Edgar Morris |
Jessica Edgar Morris is currently the Chief Operating Officer at Tonix Pharmaceuticals Holding Corp. She previously worked as a Senior Associate-Sponsor Finance Group at American Capital Ltd., Vice President at Calvert Street Capital Partners, Inc., Associate at Silicon Valley Bank, and Vice President-Investment Management at Zhongrong Group. Ms. Morris completed her undergraduate degree at the University of Virginia. |
| Margaret Smith Bell |
Margaret Smith Bell is an Independent Director at Tonix Pharmaceuticals Holding Corp. She previously worked as a Managing Director at Putnam Investments Ltd., a Portfolio Manager at Putnam Health Sciences Trust, a Vice President at abrdn Investment Management Ltd., and a Member-Overseers Board at Beth Israel Deaconess Medical Center, Inc. Bell received her undergraduate degree from Wesleyan University and her MBA from The Wharton School of the University of Pennsylvania. |
| David Lawrence Grange |
David Lawrence Grange is the founder of Osprey Global Solutions LLC, which was founded in 2009. He holds the title of President at Osprey Global Solutions LLC starting in 2011. Mr. Grange's current job(s) include Chairman-Governing Board at Indiana University since 2011, Vice Chairman at Pharm-Olam International Ltd. since 2017, Director at Vietnam Veterans Memorial Council of Bronx, Inc., Director at The Eshelman Foundation, Director at Pharm-Olam International (UK) Ltd., Director at Gettysburg Foundation, Director at New York State For Veterans, Inc., Director at ViaGlobal Group LLC, Independent Director at Tonix Pharmaceuticals Holding Corp. since 2018, Trustee at Society of the First Infantry Division, and Member at Philanthropy Roundtable. Mr. Grange's former job(s) include President & Chief Executive Officer at Robert R. McCormick Tribune Foundation, Chief Executive Officer at Pharmaceutical Product Development LLC from 2009 to 2011, Director at National Strategy Forum, Inc., Director at The Chicago Council on Global Affairs, Director at Pharm-Olam Group Ltd. from 2017 to 2020, and National Security Analyst at Cable News Network, Inc. He was also a Member of The Partnership for New Communities. Mr. Grange's education history includes graduating from the University of Western Kentucky. |
| Richard H. Bagger |
Richard H. Bagger is currently a Director at the Chamber of Commerce of The United States of America, a Director at The Leukemia & Lymphoma Society, Inc., an Independent Director at Tonix Pharmaceuticals Holding Corp., and the Executive Director & Partner at Christie 55 Solutions LLC. He previously held positions as Chairman at the National Pharmaceutical Council, Chairman at the HealthCare Institute of New Jersey, Chairman at the Gateway Program Development Corp., and EVP-Corporate Affairs & Strategic Market Access at Celgene Corp. He also worked as Senior VP-Worldwide Public Affairs & Policy at Pfizer Inc. and Assistant General Counsel at Blue Cross & Blue Shield of New Jersey, Inc. He is a graduate of Rutgers State University of New Jersey and holds an undergraduate degree from the Woodrow Wilson School of Public & International Affairs. |
| Adeoye Y. Olukotun |
Adeoye Y. Olukotun founded VIA Pharmaceuticals, Inc. in 2004, where he worked as Chief Medical Officer from 2004 to 2008 and CR Strategies LLC in 2000, where he is working as Chief Executive Officer from 2000. Dr. Olukotun also currently works at Electrophysiology Research Foundation, as Chief Executive Officer & Trustee, Arrowhead Pharmaceuticals, Inc., as Independent Director from 2020, and Tonix Pharmaceuticals Holding Corp., as Independent Director from 2018. Dr. Olukotun also formerly worked at Abcentra, Inc., as Chief Executive Officer from 2006 to 2013, Epigen Pharmaceuticals, Inc., as President & Chief Executive Officer from 2014 to 2018, Cardio Vax LLC, as Vice Chairman from 2012 to 2016, BioClinica, Inc., as Independent Director from 2011 to 2013, Nordion (Canada), Inc., as Director in 2010, Neusentis, Inc., as Director, SemBioSys Genetics, Inc., as Director in 2007, Milestone Pharmaceuticals, Inc., as Director, MDS Nordion, Inc., as Director, BioMedical Systems Corp., as Director, D&R Greenway Land Trust, Inc., as Director, Diadexus, Inc., as Independent Director from 2013 to 2015, Genesis Unicorn Capital Corp., as Director, Chief Executive & Technology Officer, Bristol Myers Squibb Co., as Vice President, Mallinckrodt, Inc.(Old), as Vice President-Medical & Regulatory Affairs from 1996 to 2000, and Esperion Therapeutics, Inc., as Chief Medical Officer & SVP-Regulatory Affairs from 2001 to 2004. Dr. Olukotun received his doctorate degree in 1973 from Albert Einstein College of Medicine, Inc., graduate degree in 1983 from Harvard T.H. Chan School of Public Health, and undergraduate degree in 1969 from UNC School of Law. |
| R. Newcomb Stillwell |
R. Newcomb Stillwell is currently the Director at the Greater Boston Chamber of Commerce and an Independent Director at Tonix Pharmaceuticals Holding Corp. Previously, he held positions as Principal at Bain Capital Ventures LP, Trustee at The Hotchkiss School, and Co-Managing Partner-Boston Office at Ropes & Gray LLP. He received his graduate degree from Harvard University in 1984, his undergraduate degree from Princeton University in 1979, and also attended Harvard Law School. |
| Jamie D. Treco |
Jamie D. Treco is currently the Lead Independent Director at Tonix Pharmaceuticals Holding Corp. since 2020. Prior to this, he was the Managing Partner at First Chicago Advisors, Inc. starting from 2009. In his former positions, Mr. Treco worked as a Principal at Citigroup, Inc. from 1996 to 2008. He also held positions as a Principal at Salomon Brothers and as a Managing Principal at Allyon Capital Partners LLC. Mr. Treco completed his undergraduate degree at Yale University in 1997. He later obtained an MBA from Stanford Graduate School of Business. |
| Carolyn E. Taylor |
Carolyn E. Taylor is an Independent Director at Tonix Pharmaceuticals Holding Corp. She previously served as the Executive Vice President & General Counsel at Longitude, Inc. from 2000 to 2003, the General Counsel at Strike Derivatives, Inc. from 2019 to 2020, and as Of Counsel at Covington & Burling LLP from 2004 to 2015. Prior to that, she was also Of Counsel at Covington & Burling LLP from 1989 to 2000. Ms. Taylor obtained her undergraduate degree from Brown University and her graduate degree from Columbia Law School. |
